Clinical Trials in Atlanta

Showing 2521-2540 of 16,968 trials

Progesterone in Gender Affirming Hormone Therapy Study

NCT06807580

This study aims to study the effects of Oral Progesterone in Transgender Women. The primary goal is to study the effect of progesterone on psychological distress and secondarily on sleep quality, breast size, quality of life and gender congruence and cardiovascular risk.

Transgender Women

Emory University40 participantsStarted May 2025

Atlanta, Georgia, United States

RECRUITING< 1 mile

Stroke Thrombectomy and Aneurysm Registry

NCT04994756

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

StrokeThromboses, IntracranialAneurysm, Brain

Medical University of South Carolina40,000 participantsStarted Sep 2019

Birmingham, Alabama, United States • Loma Linda, California, United States • Santa Barbara, California, United States +60 more locations

Progesterone in Gender Affirming Hormone Therapy Study

Stroke Thrombectomy and Aneurysm Registry

Find Trials by Condition in Atlanta

SpineTRACK Registry - Spinal Outcomes Registry

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Study of Pregnancy And Neonatal Health (SPAN)

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

SP Thoracic IDE Study

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

An Observational Study of Patients With Moderate Parkinson's Disease

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors